Urinary tract infections (UTIs) are among the most frequent bacterial infections both in community and healthcare settings [1]. The Global Burden of Diseases (GBD) has estimated an incidence of 0.4 billion UTI cases and an age-standardised mortality rate of 3.13/10.000 worldwide in 2019, with an increase of 60.4 % and 140.2 %, respectively, as compared to1990 [2] . The National Centre for Health Statistics has reported approximately 10.5 million ambulatory visits for UTI symptoms in US yearly, 21.3 % of which in emergency departments [3], while a nationwide study conducted in Sweden found that urogenital infections account for 17 % of all hospital admission for infectious diseases, with a progressive increase in incidence from 1998 to 2019 [4].
